- Home
- BFRI vs OSRH Comparison
BFRI vs OSRH Comparison
Compare BFRI & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFRI | OSRH |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 17.9M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BFRI | OSRH |
|---|---|---|
| Price | $1.42 | $0.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | 537.6K | ★ 24.9M |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,705,000.00 | $2,905,805.00 |
| Revenue This Year | $14.36 | $9.30 |
| Revenue Next Year | $16.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $0.57 | $0.25 |
| 52 Week High | $1.52 | $1.00 |
Technical Indicators
Market Signals| Indicator | BFRI | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 70.12 | 40.04 |
| Support Level | $0.77 | N/A |
| Resistance Level | N/A | $0.53 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 71.62 | 0.71 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.